Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
NASDAQ:HOLX
HOLX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$51.90 - $84.67
Previous CloseN/A
Volume386.02K
Average Volume (3M)3.40M
Market Cap
$12.10B
Enterprise Value$13.75B
Total Cash (Recent Filing)$1.62B
Total Debt (Recent Filing)$2.53B
Price to Earnings (P/E)22.9
Beta0.13
Next Earnings
Jul 23, 2025EPS Estimate
1.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.03
Shares Outstanding222,845,250
10 Day Avg. Volume2,591,641
30 Day Avg. Volume3,404,836
Financial Highlights & Ratios
PEG Ratio-0.91
Price to Book (P/B)2.77
Price to Sales (P/S)0.00
P/FCF Ratio12.16
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue0.85
Enterprise Value/Gross Profit6.60
Enterprise Value/Ebitda2.82
Forecast
1Y Price Target
$66.45Price Target Upside6.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Hologic News
Bulls Say, Bears Say
Bulls Say
Financial StabilityHOLX ended its F2Q25 with $1.6B of cash and $2.5B of debt, which positions it favorably in terms of financial stability.
Revenue GrowthHOLX expects growth to improve as it moves through FY25 and expects to end the year near its mid-single digit target.
ValuationWith valuation at 14 times forward EPS (well below the 10-year average of 18.0 times), and a path to an acceleration in revenue and earnings growth over the next few quarters, an Outperform rating is reiterated.
Bears Say
Breast Health BusinessBreast Health continues to show pronounced weakness, creating a challenging outlook for the company despite management's efforts to address these issues.
Geopolitical And Tariff ChallengesHOLX lowered its FY25 EPS guide during the F2Q call to reflect possible tariff and geopolitical tensions.
Tariff CostsTariffs are expected to cause a significant cost headwind of $20-25 million per quarter, affecting the company's surgical and interventional breast products.
Ownership Overview
1.34% Insiders
29.11% Mutual Funds
21.96% Other Institutional Investors
19.70% Public Companies and Individual Investors
HOLX FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $51.90 and its highest was $84.67 in the past 12 months.
What is Hologic’s market cap?
Hologic’s market cap is $12.10B.
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Jul 23, 2025 which is in 56 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on May 01, 2025. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.016 by $0.014.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is 1.05.
How many shares outstanding does Hologic have?
Hologic has 222,845,250 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.03 in its last earnings report, beating expectations of $1.016. Following the earnings report the stock price went down -5.447%.
Which hedge fund is a major shareholder of Hologic?
Currently, no hedge funds are holding shares in HOLX
Hologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$66.45 (6.88% Upside)
$66.45 (6.88% Upside)
Blogger Sentiment
Bullish
HOLX Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 16.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $300.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.63%
12-Months-Change
Fundamentals
Return on Equity
11.77%
Trailing 12-Months
Asset Growth
-1.94%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. is a leading global medical technology company specializing in women's health. The company operates in sectors including diagnostics, breast and skeletal health, and gynecological surgical products. Its core products and services are centered around improving women's health and well-being through innovative solutions in diagnostics, medical imaging systems, and surgical devices.
HOLX Company Deck
HOLX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflected a balanced view of Hologic's performance, with strong non-product revenue growth and diagnostics performance offset by challenges such as revenue declines, geopolitical issues in China, and the impact of tariffs.Read More>HOLX Revenue Breakdown
44.22% Diagnostics
37.79% Breast Health
15.91% GYN Surgical
2.09% Skeletal Health
HOLX Stock 12 Month Forecast
Average Price Target
$66.45
▲(6.88%Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Cooper Co
―
Resmed
―
West Pharmaceutical Services
―